167 related articles for article (PubMed ID: 25453814)
21. Copper(I) mediated facile synthesis of potent tubulin polymerization inhibitor, 9-amino-α-noscapine from natural α-noscapine.
Manchukonda NK; Sridhar B; Naik PK; Joshi HC; Kantevari S
Bioorg Med Chem Lett; 2012 Apr; 22(8):2983-7. PubMed ID: 22425569
[TBL] [Abstract][Full Text] [Related]
22. Structural Basis of Noscapine Activation for Tubulin Binding.
Oliva MA; Prota AE; Rodríguez-Salarichs J; Bennani YL; Jiménez-Barbero J; Bargsten K; Canales Á; Steinmetz MO; Díaz JF
J Med Chem; 2020 Aug; 63(15):8495-8501. PubMed ID: 32657585
[TBL] [Abstract][Full Text] [Related]
23. Elucidation of the Tubulin-targeted Mechanism of Action of 9-(3-pyridyl) Noscapine.
Pradhan S; Mahaddalkar T; Choudhary S; Manhcukonda N; Nagireddy PR; Kantevari S; Lopus M
Curr Top Med Chem; 2017; 17(22):2569-2574. PubMed ID: 28056737
[TBL] [Abstract][Full Text] [Related]
24. 9-Ethynyl noscapine induces G2/M arrest and apoptosis by disrupting tubulin polymerization in cervical cancer.
Nagireddy PKR; Kumar D; Kommalapati VK; Pedapati RK; Kojja V; Tangutur AD; Kantevari S
Drug Dev Res; 2022 May; 83(3):605-614. PubMed ID: 34612529
[TBL] [Abstract][Full Text] [Related]
25. Novel 9'-substituted-noscapines: synthesis with Suzuki cross-coupling, structure elucidation and biological evaluation.
Porcù E; Sipos A; Basso G; Hamel E; Bai R; Stempfer V; Udvardy A; Bényei AC; Schmidhammer H; Antus S; Viola G
Eur J Med Chem; 2014 Sep; 84():476-90. PubMed ID: 25050880
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and biological evaluation of di-substituted noscapine analogs as potent and microtubule-targeted anticancer agents.
Mishra RC; Gundala SR; Karna P; Lopus M; Gupta KK; Nagaraju M; Hamelberg D; Tandon V; Panda D; Reid MD; Aneja R
Bioorg Med Chem Lett; 2015; 25(10):2133-40. PubMed ID: 25891106
[TBL] [Abstract][Full Text] [Related]
27.
Meher RK; Nagireddy PKR; Pragyandipta P; Kantevari S; Singh SK; Kumar V; Naik PK
J Biomol Struct Dyn; 2022 Sep; 40(15):6725-6736. PubMed ID: 33627059
[TBL] [Abstract][Full Text] [Related]
28. Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells.
Ye K; Ke Y; Keshava N; Shanks J; Kapp JA; Tekmal RR; Petros J; Joshi HC
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1601-6. PubMed ID: 9465062
[TBL] [Abstract][Full Text] [Related]
29. Rational design of novel anti-microtubule agent (9-azido-noscapine) from quantitative structure activity relationship (QSAR) evaluation of noscapinoids.
Santoshi S; Naik PK; Joshi HC
J Biomol Screen; 2011 Oct; 16(9):1047-58. PubMed ID: 21972248
[TBL] [Abstract][Full Text] [Related]
30. Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and T-cell lymphoma.
Aneja R; Vangapandu SN; Lopus M; Chandra R; Panda D; Joshi HC
Mol Pharmacol; 2006 Jun; 69(6):1801-9. PubMed ID: 16517755
[TBL] [Abstract][Full Text] [Related]
31. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.
Jyoti K; Kaur K; Pandey RS; Jain UK; Chandra R; Madan J
J Colloid Interface Sci; 2015 May; 445():219-230. PubMed ID: 25622047
[TBL] [Abstract][Full Text] [Related]
32. Antiproliferative Noscapinoids Bearing an Amidothiadiazole Scaffold as Apoptosis Inducers: Design, Synthesis and Molecular Docking.
Kumar Pedapati R; Pragyandipta P; Pranathi Abburi N; Chirra N; Kantevari S; Naik PK
Chem Biodivers; 2023 Feb; 20(2):e202201089. PubMed ID: 36690497
[TBL] [Abstract][Full Text] [Related]
33. Development of 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents for the management of breast cancer.
Meher RK; Pragyandipta P; Reddy PK; Pedaparti R; Kantevari S; Naik PK
J Biomol Struct Dyn; 2022; 40(23):13136-13153. PubMed ID: 34583618
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and Pharmacological Evaluation of Noscapine-Inspired 5-Substituted Tetrahydroisoquinolines as Cytotoxic Agents.
Devine SM; Yong C; Amenuvegbe D; Aurelio L; Muthiah D; Pouton C; Callaghan R; Capuano B; Scammells PJ
J Med Chem; 2018 Sep; 61(18):8444-8456. PubMed ID: 30156410
[TBL] [Abstract][Full Text] [Related]
35. Identification of novel anti-cancer agents by the synthesis and cellular screening of a noscapine-based library.
Nemati F; Bischoff-Kont I; Salehi P; Nejad-Ebrahimi S; Mohebbi M; Bararjanian M; Hadian N; Hassanpour Z; Jung Y; Schaerlaekens S; Lucena-Agell D; Oliva MA; Fürst R; Nasiri HR
Bioorg Chem; 2021 Oct; 115():105135. PubMed ID: 34303039
[TBL] [Abstract][Full Text] [Related]
36. Determination of noscapine's localization and interaction with the tubulin-α/β heterodimer.
Alisaraie L; Tuszynski JA
Chem Biol Drug Des; 2011 Oct; 78(4):535-46. PubMed ID: 21781284
[TBL] [Abstract][Full Text] [Related]
37. Tubulin- and ROS-dependent antiproliferative mechanism of a potent analogue of noscapine, N-propargyl noscapine.
Nambiar N; Nagireddy PKR; Pedapati R; Kantevari S; Lopus M
Life Sci; 2020 Oct; 258():118238. PubMed ID: 32791146
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of a cyclic ether fluorinated noscapine analog.
Aneja R; Vangapandu SN; Joshi HC
Bioorg Med Chem; 2006 Dec; 14(24):8352-8. PubMed ID: 17008104
[TBL] [Abstract][Full Text] [Related]
39. Rational design, synthesis and biological evaluations of amino-noscapine: a high affinity tubulin-binding noscapinoid.
Naik PK; Chatterji BP; Vangapandu SN; Aneja R; Chandra R; Kanteveri S; Joshi HC
J Comput Aided Mol Des; 2011 May; 25(5):443-54. PubMed ID: 21544622
[TBL] [Abstract][Full Text] [Related]
40. Imidazo[2,1-
Nagireddy PKR; Kommalapati VK; Siva Krishna V; Sriram D; Tangutur AD; Kantevari S
ACS Omega; 2019 Nov; 4(21):19382-19398. PubMed ID: 31763563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]